HomeCompareHNGZY vs MO

HNGZY vs MO: Dividend Comparison 2026

HNGZY yields 0.72% · MO yields 6.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HNGZY wins by $1.60M in total portfolio value
10 years
HNGZY
HNGZY
● Live price
0.72%
Share price
$4.00
Annual div
$0.03
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.68M
Annual income
$1,324,338.59
Full HNGZY calculator →
MO
Altria Group Inc.
● Live price
6.36%
Share price
$65.99
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80.1K
Annual income
$30,159.17
Full MO calculator →

Portfolio growth — HNGZY vs MO

📍 HNGZY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHNGZYMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HNGZY + MO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HNGZY pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HNGZY
Annual income on $10K today (after 15% tax)
$61.54/yr
After 10yr DRIP, annual income (after tax)
$1,125,687.80/yr
MO
Annual income on $10K today (after 15% tax)
$540.99/yr
After 10yr DRIP, annual income (after tax)
$25,635.29/yr
At 15% tax rate, HNGZY beats the other by $1,100,052.51/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HNGZY + MO for your $10,000?

HNGZY: 50%MO: 50%
100% MO50/50100% HNGZY
Portfolio after 10yr
$877.9K
Annual income
$677,248.87/yr
Blended yield
77.14%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

HNGZY
No analyst data
Altman Z
7.2
Piotroski
7/9
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-7.2% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HNGZY buys
0
MO buys
0
No recent congressional trades found for HNGZY or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHNGZYMO
Forward yield0.72%6.36%
Annual dividend / share$0.03$4.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%22.6%
Portfolio after 10y$1.68M$80.1K
Annual income after 10y$1,324,338.59$30,159.17
Total dividends collected$1.62M$74.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: HNGZY vs MO ($10,000, DRIP)

YearHNGZY PortfolioHNGZY Income/yrMO PortfolioMO Income/yrGap
1← crossover$10,845$144.81$10,570$780.30+$275.00HNGZY
2$11,897$293.53$11,381$1,032.90+$516.00HNGZY
3$13,332$601.91$12,535$1,392.73+$797.00HNGZY
4$15,526$1,260.74$14,193$1,920.91+$1.3KHNGZY
5$19,357$2,744.31$16,618$2,723.68+$2.7KHNGZY
6$27,108$6,395.29$20,263$3,993.80+$6.8KHNGZY
7$45,745$16,739.89$25,936$6,098.36+$19.8KHNGZY
8$101,749$52,802.12$35,166$9,775.01+$66.6KHNGZY
9$328,397$219,525.46$51,026$16,597.78+$277.4KHNGZY
10$1,675,724$1,324,338.59$80,113$30,159.17+$1.60MHNGZY

HNGZY vs MO: Complete Analysis 2026

HNGZYStock

Hangzhou Tigermed Consulting Co., Ltd. provides contract research organization services in the People's Republic of China and internationally. It operates in Clinical Trial Solutions, and Clinical-related and Laboratory Services segments. The company offers regulatory submission and approval, medical translation, and good manufacturing practice (GMP) consulting services; and clinical services in the areas of medical science, early clinical and late phase development, medical monitoring, project management, patient recruitment, and quality management system. It also provides biometrics services comprising data management, biostatistics, and statistical programming; and integrated technology services, such as site management, pharmacovigilance, third party audit and training, medical imaging, clinical trial system solution, central laboratory, pre-clinical, and research hospital. Further, the company offers medical device/ in vitro diagnostics (IVD) services comprising medical device testing, regulatory submission, clinical evaluation and trials, GMP certificate, EU MDR and IVDR preparation, and value-added services; and post-marketing study, real world evidence, and vaccine clinical trial services. Hangzhou Tigermed Consulting Co., Ltd. was incorporated in 2004 and is headquartered in Hangzhou, the People's Republic of China.

Full HNGZY Calculator →

MOConsumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this HNGZY vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HNGZY vs SCHDHNGZY vs JEPIHNGZY vs OHNGZY vs KOHNGZY vs MAINHNGZY vs PMHNGZY vs BTIHNGZY vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.